Tirzepatide 10MG
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
- Delivery & Return
Delivery
We ship to all address in Canada and all 50 states, Washington DC. All orders are shipped with a Canada Post tracking number. Always free shipping for orders over $500. During sale periods and promotions the delivery time may be longer than normal. Items marked "On-Demand" "Special Order" "On Backorder" are not refundable or eligible for return as they are ordered on a case by case basis.Return
Due to the nature of the products we sell, and for health safety concerns for our valuable customers, our products are non-returnable (sales are final). This policy will be strictly enforced.Help
Give us a shout if you have any other questions and/or concerns. Email:Â sales@mecp.ca Phone: +1 (437) 990-9174 - Ask a Question
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers have investigated tirzepatide in models and clinical research involving incretin biology, glucose regulation pathways, and appetite related signaling.
As an engineered incretin mimetic peptide, tirzepatide is of interest in research that compares GIP receptor and GLP 1 receptor activity, including how dual agonism may differ from single receptor approaches. Analytical work commonly focuses on identity confirmation and peptide characterization using methods such as LC MS and related assays.
- Specification: 10MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Superdrol / Methyldrostanolone 50mg/ml, 10ml refers to a defined concentration and volume format of methyldrostanolone, a 17 alpha alkylated synthetic anabolic androgenic steroid related to dihydrotestosterone analogues. Researchers have examined methyldrostanolone in studies of androgen receptor activity and anabolic androgenic structure activity relationships.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Trenbolone Acetate 75Mg; Trenbolone Enanthate 75Mg; Trenbolone Hexahydrobenzylcarbonate (Parabolan) 75Mg – 200mg/ml, 10 ml is a multi ester trenbolone preparation specified at 200 mg per mL in a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from 19 nortestosterone, and researchers may use it when studying androgen receptor signaling and steroid structure activity relationships. Work in preclinical and analytical settings has examined trenbolone esters for differences in lipophilicity, hydrolysis rates, and detection profiles.
In Stock
Masteron / Drostanolone Propionate 100mg/ml 10ml is a preparation of drostanolone propionate, an androgenic anabolic steroid derived from dihydrotestosterone. Researchers may reference drostanolone in studies involving androgen receptor signaling and steroid structure activity relationships. It is also encountered in analytical work focused on identification, profiling, and method development for anabolic agents.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Trenbolone Acetate (Tra) 100mg/ml 10ml is a specified concentration and volume format of trenbolone acetate, an acetate ester of trenbolone and a synthetic anabolic androgenic steroid. Researchers may reference trenbolone acetate in studies involving androgen receptor signaling, steroid ester pharmacokinetics, and analytical method development. It is also encountered in forensic and anti doping research workflows focused on steroid identification.
In Stock
Winstrol 100mg/ml 10ml refers to a 100 milligram per millilitre concentration supplied in a 10 millilitre format of stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers may reference stanozolol in studies involving androgen receptor signaling, anabolic steroid structure activity relationships, and metabolism profiling.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Winstrol 100mg ml 10ml is a concentration and volume format commonly associated with stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers and analytical labs may examine stanozolol in contexts such as receptor binding assays, metabolic profiling, and method development for detection and quantification.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
















